Drug Shortage Report for TEVA-NABILONE
Report ID | 2256 |
Drug Identification Number | 02384884 |
Brand name | TEVA-NABILONE |
Common or Proper name | NABILONE |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | NABILONE |
Strength(s) | 0.5MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 50 |
ATC code | A04AD |
ATC description | ANTIEMETICS AND ANTINAUSEANTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2018-02-15 |
Actual start date | 2018-02-15 |
Estimated end date | 2018-07-15 |
Actual end date | 2018-08-30 |
Shortage status | Resolved |
Updated date | 2018-09-13 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-03-14 | English | Compare |
v2 | 2017-03-14 | French | Compare |
v3 | 2017-04-03 | English | Compare |
v4 | 2017-04-03 | French | Compare |
v5 | 2017-04-29 | English | Compare |
v6 | 2017-07-27 | English | Compare |
v7 | 2017-07-27 | French | Compare |
v8 | 2017-09-16 | English | Compare |
v9 | 2017-10-10 | English | Compare |
v10 | 2017-10-10 | French | Compare |
v11 | 2017-11-23 | English | Compare |
v12 | 2017-11-23 | French | Compare |
v13 | 2018-02-16 | English | Compare |
v14 | 2018-03-07 | English | Compare |
v15 | 2018-03-07 | French | Compare |
v16 | 2018-07-03 | English | Compare |
v17 | 2018-07-03 | French | Compare |
v18 | 2018-09-13 | English | Compare |
v19 | 2018-09-13 | French | Compare |
Showing 1 to 19 of 19